LETTER
Synthesis of 1,2,4-Oxadiazine Derivatives
1585
(8) One-Pot Procedure for the Preparation of 1,2-Diaza-1,3-
butadiene Derivatives 4a–j
Acknowledgment
This work was supported by financial assistance from the Ministero
dell’Istruzione, dell’Università e della Ricerca (MIUR), and the
Università degli Studi di Urbino ‘Carlo Bo’.
1,2-Diazabuta-1,3-diene 1a–f (1 mmol), prepared and used
as a EE/EZ-isomer mixture,6a and arylamidoxime 2a–c (1
mmol) were dissolved in alcohol (8 mL) with magnetic
stirring, and the reaction mixture was allowed to stand at r.t.
until disappearance of the reagents and the formation of
Michael adduct 3a–j (0.33–4.0 h, monitored by SiO2 TLC).
A stoichiometric amount of NaH was added, and the crude
reaction mixture was allowed to stand at r.t. until the
complete disappearance of 3a–j was observed by TLC
analysis (0.5–8.0 h). After removal of the solvent in vacuo,
the residue was suspended in H2O, neutralized with 2 N HCl,
extracted with CH2Cl2, and the organic extracts dried. After
filtering, the organic solvent was evaporated, and the solid
residue was crystallized from the appropriate solvent.
(9) Data for Michael Adduct 3f
White powder from EtOAc–n-pentane, mp 99–100 °C
(dec.). IR (KBr): 3490, 3395, 2995, 1765, 1730, 1700, 1640,
1590, 1545 cm–1. 1H NMR (400 MHz, DMSO-d6): d = 1.91
(s, 3 H, CH3), 3.67 (s, 6 H, 2 × OCH3), 4.98 (s, 1 H, CH),
6.29 (s, 2 H, NH2), 7.36–7.43 (m, 3 H, Ar), 7.61 (d, J = 8.0
Hz, 2 H, Ar), 10.15 (s, 1 H, NH). 13C NMR (100 MHz
DMSO-d6): d = 12.90, 51.86, 51.93, 84.33, 126.08, 128.20,
129.72, 132.07, 148.14, 152.82, 154.46, 169.25. MS: m/z
(%) = 322 [M+] (0.6), 291 (0.5), 263 (1), 249 (1), 136 (15),
115 (58), 83 (100). Anal. Calcd for C14H17N3O5: C, 54.72; H,
5.58; N, 13.67. Found: C, 54.73; H, 5.61; N, 13.62.
(10) Data for Methyl 2-[1-(5-Oxo-3-phenyl-5,6-dihydro-4H-
1,2,4-oxadiazin-6-yliden)ethyl]-1-hydrazinecarboxylate
(4f)
References and Notes
(1) (a) Qian, X.; Bergnes, G.; Morgans, D. J. WO 2004091547,
2004. (b) Mezei, J.; Küttel, S.; Szemere, L.; Rácz, I.
Pharmazie 1984, 39, 397. (c) Weller, H. N.; Miller, A. V.;
Dickinson, K. E. J.; Hedberg, S. A.; Delaney, C. L.;
Serafino, R. P.; Moreland, S. Heterocycles 1993, 36, 1027.
(2) (a) Berkowitz, P. T.; Long, R. A.; Dea, P.; Robins, R. K.;
Matthews, T. R. J. Med. Chem. 1977, 20, 134. (b) Khan,
K. M.; Rahat, S.; Choudhary, M. I.; Atta-ur-Rahman; Ghani,
U.; Perveen, S.; Khatoon, S.; Dar, A.; Malik, A. Helv. Chim.
Acta 2002, 85, 559. (c) Arikan, N.; Sumengen, D.; Dulger,
B. Turk. J. Chem. 2008, 32, 147.
(3) Fylaktakidou, K. C.; Hadjipavlou-Litina, D. J.; Litinas,
K. E.; Varella, E. A.; Nicolaides, D. N. Curr. Pharm. Des.
2008, 1001.
(4) (a) Clapp, L. B. In Advances in Heterocyclic Chemistry,
Vol. 20; Katritzky, A. R., Ed.; Academic Press: New York,
1976, 65–116. (b) Hébert, N.; Hannah, A. L.; Sutton, S. C.
Tetrahedron Lett. 1999, 40, 8547. (c) Crestey, F.; Lebargi,
C.; Lasne, M.-C.; Perrio, C. Synthesis 2007, 3406. (d) Du,
W.; Truong, Q.; Qi, H.; Guo, Y.; Chobanian, H. R.;
Hagmann, W. K.; Hale, J. J. Tetrahedron Lett. 2007, 48,
2231. (e) Braga, A. L.; Lüdtke, D. S.; Alberto, E. E.;
Dorneller, L.; Severo Filho, W. A.; Corbellini, V. A.; Rosa,
D. M.; Schwab, R. S. Synthesis 2004, 1589. (f) Ispikoudi,
M.; Litinas, K. E.; Fylaktakidou, K. C. Heterocycles 2008,
75, 1321. (g) Hamze, A.; Hernandez, J. F.; Fulcrand, P.;
Martinez, J. J. Org: Chem. 2003, 68, 7316. (h) Zhou, T.;
Chen, Z.-C. Synth. Commun. 2002, 32, 887.
(5) (a) Durust, Y.; Altug, C.; Kilic, F. Phosphorus, Sulfur
Silicon Relat. Elem. 2007, 182, 299. (b) Srivastava, R. M.;
De Morais, L. P. F.; De Melo Souto, S. C.; Carpenter, G. B.;
De Carvalho, L. T. Tetrahedron Lett. 2006, 47, 3173.
(c) Hussein, A. Q. Heterocycles 1987, 26, 163. (d) Tabei,
K.; Kawashima, E.; Takada, T.; Kato, T. Chem. Pharm.
Bull. 1982, 30, 3987. (e) Santilli, A. A.; Scotese, A. C.
J. Heterocycl. Chem. 1979, 16, 213.
Pink powder from CH2Cl2–PE (40–60 °C), mp 148–149 °C
(dec.). IR (KBr): 3420, 3390, 3320, 2990, 1770, 1740, 1620,
1575 cm–1. 1H NMR (400 MHz, DMSO-d6): d = 1.97 (s, 3 H,
CH3), 3.61 (s, 3 H, OCH3), 6.88 (br s, 1 H, NH), 7.52–7.63
(m, 3 H, Ar), 7.98 (d, J = 6.8 Hz, 2 H, Ar), 9.93 (br s, 1 H,
NH), 11.43 (br s, 1 H, NH). 13C NMR (100 MHz DMSO-d6):
d = 12.12, 51.81, 93.61, 127.25, 128.30, 128.85, 132.48,
152.38, 154.36, 160.94, 181.72. ESI-MS: m/z calcd for
C13H14N4O4: 290.1; found: 291 [M+1].
(11) Attanasi, O. A.; De Crescentini, L.; Favi, G.; Filippone, P.;
Golobič, A.; Lillini, S.; Mantellini, F. Synlett 2006, 2735.
(12) Typical One-Pot Procedure for the Synthesis of
Spirocycloalkyl-1,2,4-oxadiazin-5-one Derivatives 5a–d
To a solution of arylamidoxime 2b,c (1 mmol) in EtOH (4
mL), 1-cycloalkenyl-1-diazene 1g–j (1 mmol), prepared as
previously reported and dissolved in EtOH (4 mL), was
added dropwise at r.t. with magnetic stirring. The reaction
mixture was allowed to stand at r.t. until the disappearance
of the reactants (0.5–6.0 h) and the formation of the pertinent
1,4-adduct 3. The crude reaction mixture was then treated
with NaH (1 equiv) until complete disappearance of the
intermediate was observed by TLC analysis (0.5–4.0 h).
After removal of the solvent in vacuo, the residue was
suspended in H2O, neutralized with 2 N HCl, extracted with
CH2Cl2, and the organic extracts dried. After filtering, the
organic solvent was evaporated and the solid residue was
crystallized from the appropriate solvent.
(6) (a) Attanasi, O. A.; De Crescentini, L.; Filippone, P.;
Mantellini, F.; Santeusanio, S. ARKIVOC 2002, (xi), 274;
and references cited therein. (b) Attanasi, O. A.;
De Crescentini, L.; Favi, G.; Filippone, P.; Mantellini, F.;
Santeusanio, S. Synlett 2004, 549. (c) Attanasi, O. A.;
Carvoli, G.; Filippone, P.; Perrulli, F. R.; Santeusanio, S.;
Serri, A. M. Synlett 2004, 1643. (d) Attanasi, O. A.;
Baccolini, G.; Boga, C.; De Crescentini, L.; Filippone, P.;
Mantellini, F. J. Org. Chem. 2005, 70, 4033. (e) Attanasi,
O. A.; De Crescentini, L.; Favi, G.; Filippone, P.; Lillini,
S. P.; Mantellini, F.; Santeusanio, S. Synlett 2005, 1474.
(f) Palacios, F.; Aparicio, D.; López, Y.; de los Santos, J. M.
Tetrahedron 2005, 61, 2815. (g) Attanasi, O. A.; Abbiati,
G.; Rizzato, S.; Rossi, E.; Santeusanio, S. Tetrahedron 2007,
63, 11055. (h) Attanasi, O. A.; Davoli, P.; Favi, G.;
Filippone, P.; Forni, A.; Moscatelli, G.; Prati, F. Org. Lett.
2007, 9, 3461. (i) Attanasi, O. A.; Favi, G.; Filippone, P.;
Perrulli, F. R.; Santeusanio, S. Org. Lett. 2009, 11, 309.
(7) Attanasi, O. A.; Favi, G.; Filippone, P.; Giorgi, G.; Lillini,
S.; Mantellini, F.; Perrulli, F. R. Synlett 2006, 2731.
(13) Data for Methyl 2-{12-Oxo-9-phenyl-7-oxa-8,11-
diazaspiro[5.6]dodec-8-en-1-yliden}-1-hydrazine-
carboxylate (5b)
White powder from THF–n-pentane, mp 218–219 °C (dec.).
IR (Nujol): 3368, 3187, 1749, 1713, 1616 cm–1. 1H NMR
(400 MHz, DMSO-d6): d = 1.34–1.40 (m, 1 H, cy), 1.66–
1.99 (m, 5 H, cy), 2.19–2.27 (m, 1 H, cy), 2.90–2.94 (m, 1 H,
Synlett 2009, No. 10, 1583–1586 © Thieme Stuttgart · New York